Other Liabilities, Noncurrent of LIFECORE BIOMEDICAL, INC. \DE\ from 29 May 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
LIFECORE BIOMEDICAL, INC. \DE\ quarterly Other Liabilities, Noncurrent in USD history and change rate from 29 May 2011 to 30 Sep 2025.
  • LIFECORE BIOMEDICAL, INC. \DE\ Other Liabilities, Noncurrent for the quarter ending 30 Sep 2025 was $7,965,000, a 56% increase year-over-year.
Source SEC data
View on sec.gov
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Change (%)

LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Other Liabilities, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $7,965,000 +$2,851,000 +56% 30 Sep 2025 10-Q 06 Nov 2025 2026 Q1
Q2 2025 $9,741,000 -$2,320,000 -19% 25 May 2025 10-Q 06 Nov 2025 2026 Q1
Q1 2025 $9,806,000 +$4,753,000 +94% 23 Feb 2025 10-Q 03 Apr 2025 2025 Q3
Q4 2024 $5,153,000 +$4,970,000 +2716% 24 Nov 2024 10-Q 02 Jan 2025 2025 Q2
Q3 2024 $5,114,000 +$4,895,000 +2235% 25 Aug 2024 10-Q 04 Oct 2024 2025 Q1
Q2 2024 $12,061,000 +$11,887,000 +6832% 26 May 2024 10-K 07 Aug 2025 2025 FY
Q1 2024 $5,053,000 +$4,850,000 +2389% 25 Feb 2024 10-Q 09 Aug 2024 2024 Q3
Q4 2023 $183,000 -$18,000 -9% 26 Nov 2023 10-Q 09 Aug 2024 2024 Q2
Q3 2023 $219,000 +$20,000 +10% 27 Aug 2023 10-Q 09 Aug 2024 2024 Q1
Q2 2023 $174,000 -$16,000 -8.4% 28 May 2023 10-K 26 Aug 2024 2024 FY
Q1 2023 $203,000 -$341,000 -63% 26 Feb 2023 10-K 20 Mar 2024 2023 FY
Q4 2022 $201,000 -$1,731,000 -90% 27 Nov 2022 10-K 20 Mar 2024 2023 FY
Q3 2022 $199,000 -$2,177,000 -92% 28 Aug 2022 10-K 20 Mar 2024 2023 FY
Q2 2022 $190,000 -$2,680,000 -93% 29 May 2022 10-K 20 Mar 2024 2023 FY
Q1 2022 $544,000 -$2,488,000 -82% 27 Feb 2022 10-K 20 Mar 2024 2023 FY
Q4 2021 $1,932,000 -$2,092,000 -52% 28 Nov 2021 10-K 20 Mar 2024 2023 FY
Q3 2021 $2,376,000 -$1,762,000 -43% 29 Aug 2021 10-K 20 Mar 2024 2023 FY
Q2 2021 $2,870,000 -$1,682,000 -37% 30 May 2021 10-K 20 Mar 2024 2023 FY
Q1 2021 $3,032,000 +$1,568,000 +107% 28 Feb 2021 10-K 20 Mar 2024 2023 FY
Q4 2020 $4,024,000 29 Nov 2020 10-K 20 Mar 2024 2023 FY
Q3 2020 $4,138,000 30 Aug 2020 10-K 20 Mar 2024 2023 FY
Q2 2020 $4,552,000 +$2,814,000 +162% 31 May 2020 10-K 29 Jul 2021 2021 FY
Q1 2020 $1,464,000 23 Feb 2020 10-Q 03 Apr 2020 2020 Q3
Q2 2019 $1,738,000 26 May 2019 10-K 14 Aug 2020 2020 FY
Q2 2015 $1,691,000 -$330,000 -16% 31 May 2015 10-K 31 Jul 2015 2015 FY
Q3 2014 $1,403,000 -$52,000 -3.6% 31 Aug 2014 10-Q 08 Oct 2014 2015 Q1
Q2 2014 $2,021,000 +$672,000 +50% 25 May 2014 10-K 31 Jul 2015 2015 FY
Q1 2014 $1,785,000 -$180,000 -9.2% 23 Feb 2014 10-Q 28 Mar 2014 2014 Q3
Q4 2013 $1,625,000 -$237,000 -13% 24 Nov 2013 10-Q 03 Jan 2014 2014 Q2
Q3 2013 $1,455,000 +$106,000 +7.9% 25 Aug 2013 10-Q 26 Sep 2013 2014 Q1
Q2 2013 $1,349,000 +$241,000 +22% 26 May 2013 10-K 01 Aug 2014 2014 FY
Q1 2013 $1,965,000 +$804,000 +69% 24 Feb 2013 10-Q 04 Apr 2013 2013 Q3
Q4 2012 $1,862,000 +$645,000 +53% 25 Nov 2012 10-Q 04 Jan 2013 2013 Q2
Q3 2012 $1,349,000 +$25,000 +1.9% 26 Aug 2012 10-Q/A 02 Jan 2013 2013 Q1
Q2 2012 $1,108,000 -$9,945,000 -90% 27 May 2012 10-K 07 Aug 2013 2013 FY
Q1 2012 $1,161,000 26 Feb 2012 10-Q 28 Mar 2012 2012 Q3
Q4 2011 $1,217,000 27 Nov 2011 10-Q 05 Jan 2012 2012 Q2
Q3 2011 $1,324,000 28 Aug 2011 10-Q 05 Oct 2011 2012 Q1
Q2 2011 $11,053,000 29 May 2011 10-K 08 Aug 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.